Literature DB >> 35258170

Progranulin mutations in clinical and neuropathological Alzheimer's disease.

Badri N Vardarajan1,2,3, Dolly Reyes-Dumeyer1,2,3, Angel L Piriz1,2, Rafael A Lantigua1,4, Martin Medrano5, Diones Rivera6,7, Ivonne Z Jiménez-Velázquez8, Eden Martin9, Margaret A Pericak-Vance9, William Bush10, Lindsay Farrer11, Jonathan L Haines10, Li-San Wang12, Yuk Yee Leung12, Gerard Schellenberg12, Walter Kukull13, Philip De Jager1,3, David A Bennett14, Julie A Schneider14, Richard Mayeux1,2,3,13,15.   

Abstract

INTRODUCTION: Progranulin (GRN) mutations occur in frontotemporal lobar degeneration (FTLD) and in Alzheimer's disease (AD), often with TDP-43 pathology.
METHODS: We determined the frequency of rs5848 and rare, pathogenic GRN mutations in two autopsy and one family cohort. We compared Braak stage, β-amyloid load, hyperphosphorylated tau (PHFtau) tangle density and TDP-43 pathology in GRN carriers and non-carriers.
RESULTS: Pathogenic GRN mutations were more frequent in all cohorts compared to the Genome Aggregation Database (gnomAD), but there was no evidence for association with AD. Pathogenic GRN carriers had significantly higher PHFtau tangle density adjusting for age, sex and APOE ε4 genotype. AD patients with rs5848 had higher frequencies of hippocampal sclerosis and TDP-43 deposits. Twenty-two rare, pathogenic GRN variants were observed in the family cohort. DISCUSSION: GRN mutations in clinical and neuropathological AD increase the burden of tau-related brain pathology but show no specific association with β-amyloid load or AD.
© 2022 The Authors. Alzheimer's & Dementia published by Wiley Periodicals LLC on behalf of Alzheimer's Association.

Entities:  

Keywords:  Alzheimer's disease; TDP43; neuropathology; progranulin

Year:  2022        PMID: 35258170      PMCID: PMC9360185          DOI: 10.1002/alz.12567

Source DB:  PubMed          Journal:  Alzheimers Dement        ISSN: 1552-5260            Impact factor:   16.655


  49 in total

Review 1.  Epidemiology of neurodegeneration.

Authors:  Richard Mayeux
Journal:  Annu Rev Neurosci       Date:  2003-01-24       Impact factor: 12.449

2.  Prevalence and correlates of depressive symptoms among older U.S. adults.

Authors:  L Stallones; M B Marx; T F Garrity
Journal:  Am J Prev Med       Date:  1990 Sep-Oct       Impact factor: 5.043

3.  The Alzheimer's Disease Sequencing Project: Study design and sample selection.

Authors:  Gary W Beecham; J C Bis; E R Martin; S-H Choi; A L DeStefano; C M van Duijn; M Fornage; S B Gabriel; D C Koboldt; D E Larson; A C Naj; B M Psaty; W Salerno; W S Bush; T M Foroud; E Wijsman; L A Farrer; A Goate; J L Haines; Margaret A Pericak-Vance; E Boerwinkle; R Mayeux; S Seshadri; G Schellenberg
Journal:  Neurol Genet       Date:  2017-10-13

Review 4.  Frontotemporal lobar degeneration: Pathogenesis, pathology and pathways to phenotype.

Authors:  David M A Mann; Julie S Snowden
Journal:  Brain Pathol       Date:  2017-03-02       Impact factor: 6.508

Review 5.  Progranulin mutations as risk factors for Alzheimer disease.

Authors:  David C Perry; Manja Lehmann; Jennifer S Yokoyama; Anna Karydas; Jason Jiyong Lee; Giovanni Coppola; Lea T Grinberg; Dan Geschwind; William W Seeley; Bruce L Miller; Howard Rosen; Gil Rabinovici
Journal:  JAMA Neurol       Date:  2013-06       Impact factor: 18.302

6.  Novel GRN Mutations in Alzheimer's Disease and Frontotemporal Lobar Degeneration.

Authors:  Irene Piaceri; Daniele Imperiale; Enrico Ghidoni; Cristiana Atzori; Silvia Bagnoli; Camilla Ferrari; Silvana Ungari; Luca Ambrogio; Sandro Sorbi; Benedetta Nacmias
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

7.  PGRN Is Associated with Late-Onset Alzheimer's Disease: a Case-Control Replication Study and Meta-analysis.

Authors:  Hui-Min Xu; Lin Tan; Yu Wan; Meng-Shan Tan; Wei Zhang; Zhan-Jie Zheng; Ling-Li Kong; Zi-Xuan Wang; Teng Jiang; Lan Tan; Jin-Tai Yu
Journal:  Mol Neurobiol       Date:  2016-01-28       Impact factor: 5.590

8.  Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease.

Authors:  Adam C Naj; Gyungah Jun; Gary W Beecham; Li-San Wang; Badri Narayan Vardarajan; Jacqueline Buros; Paul J Gallins; Joseph D Buxbaum; Gail P Jarvik; Paul K Crane; Eric B Larson; Thomas D Bird; Bradley F Boeve; Neill R Graff-Radford; Philip L De Jager; Denis Evans; Julie A Schneider; Minerva M Carrasquillo; Nilufer Ertekin-Taner; Steven G Younkin; Carlos Cruchaga; John S K Kauwe; Petra Nowotny; Patricia Kramer; John Hardy; Matthew J Huentelman; Amanda J Myers; Michael M Barmada; F Yesim Demirci; Clinton T Baldwin; Robert C Green; Ekaterina Rogaeva; Peter St George-Hyslop; Steven E Arnold; Robert Barber; Thomas Beach; Eileen H Bigio; James D Bowen; Adam Boxer; James R Burke; Nigel J Cairns; Chris S Carlson; Regina M Carney; Steven L Carroll; Helena C Chui; David G Clark; Jason Corneveaux; Carl W Cotman; Jeffrey L Cummings; Charles DeCarli; Steven T DeKosky; Ramon Diaz-Arrastia; Malcolm Dick; Dennis W Dickson; William G Ellis; Kelley M Faber; Kenneth B Fallon; Martin R Farlow; Steven Ferris; Matthew P Frosch; Douglas R Galasko; Mary Ganguli; Marla Gearing; Daniel H Geschwind; Bernardino Ghetti; John R Gilbert; Sid Gilman; Bruno Giordani; Jonathan D Glass; John H Growdon; Ronald L Hamilton; Lindy E Harrell; Elizabeth Head; Lawrence S Honig; Christine M Hulette; Bradley T Hyman; Gregory A Jicha; Lee-Way Jin; Nancy Johnson; Jason Karlawish; Anna Karydas; Jeffrey A Kaye; Ronald Kim; Edward H Koo; Neil W Kowall; James J Lah; Allan I Levey; Andrew P Lieberman; Oscar L Lopez; Wendy J Mack; Daniel C Marson; Frank Martiniuk; Deborah C Mash; Eliezer Masliah; Wayne C McCormick; Susan M McCurry; Andrew N McDavid; Ann C McKee; Marsel Mesulam; Bruce L Miller; Carol A Miller; Joshua W Miller; Joseph E Parisi; Daniel P Perl; Elaine Peskind; Ronald C Petersen; Wayne W Poon; Joseph F Quinn; Ruchita A Rajbhandary; Murray Raskind; Barry Reisberg; John M Ringman; Erik D Roberson; Roger N Rosenberg; Mary Sano; Lon S Schneider; William Seeley; Michael L Shelanski; Michael A Slifer; Charles D Smith; Joshua A Sonnen; Salvatore Spina; Robert A Stern; Rudolph E Tanzi; John Q Trojanowski; Juan C Troncoso; Vivianna M Van Deerlin; Harry V Vinters; Jean Paul Vonsattel; Sandra Weintraub; Kathleen A Welsh-Bohmer; Jennifer Williamson; Randall L Woltjer; Laura B Cantwell; Beth A Dombroski; Duane Beekly; Kathryn L Lunetta; Eden R Martin; M Ilyas Kamboh; Andrew J Saykin; Eric M Reiman; David A Bennett; John C Morris; Thomas J Montine; Alison M Goate; Deborah Blacker; Debby W Tsuang; Hakon Hakonarson; Walter A Kukull; Tatiana M Foroud; Jonathan L Haines; Richard Mayeux; Margaret A Pericak-Vance; Lindsay A Farrer; Gerard D Schellenberg
Journal:  Nat Genet       Date:  2011-04-03       Impact factor: 38.330

9.  Progranulin protects against amyloid β deposition and toxicity in Alzheimer's disease mouse models.

Authors:  S Sakura Minami; Sang-Won Min; Grietje Krabbe; Chao Wang; Yungui Zhou; Rustam Asgarov; Yaqiao Li; Lauren H Martens; Lisa P Elia; Michael E Ward; Lennart Mucke; Robert V Farese; Li Gan
Journal:  Nat Med       Date:  2014-09-28       Impact factor: 53.440

Review 10.  Translating the biology of aging into novel therapeutics for Alzheimer disease.

Authors:  Yuko Hara; Nicholas McKeehan; Howard M Fillit
Journal:  Neurology       Date:  2018-12-07       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.